Clinical trial
Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable…
NCT00208936 · Emory University, Other · Terminated
Key facts
| NCT number | NCT00208936 |
|---|---|
| Title | Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus |
| Official title | Phase II Study of Pre-Operative Chemotherapy With Taxol, Cisplatin, and 5-Fluorouracil Followed by G-CSF in Patients With Resectable Local-Regional Carcinoma of Esophagus |
| Lead sponsor | Emory University, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Diseases |
| Intervention type | Drug |
| Interventions | Taxol, Cisplatin, 5-Fluorouracil, G-CSF |
| Enrollment | 20 |
| Start date | Jan 1, 1996 |
| Primary completion | Mar 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 9, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: